3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/5022100

Download in:

View as

General Info

PMID
5022100